awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34386577-46680B5C-9266-4A21-A606-C4BA0A55A568
Q34386577-46680B5C-9266-4A21-A606-C4BA0A55A568
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34386577-46680B5C-9266-4A21-A606-C4BA0A55A568
Critical appraisal of cabazitaxel in the management of advanced prostate cancer
P2860
Q34386577-46680B5C-9266-4A21-A606-C4BA0A55A568
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34386577-46680B5C-9266-4A21-A606-C4BA0A55A568
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2489073ef6634011ab72497cbf6df806ac4b7f7a
P2860
Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer